Xu S, He J, Liu Z, Pei Y, et al. Immune-related adverse events as prognostic biomarkers in recurrent or metastatic nasopharyngeal carcinoma receiving PD-L1 inhibitor: A post-hoc analysis of the multicenter, single-arm, phase 2 study. Oral Oncol 2025;161:107161.
PMID: 39746267